Schonfeld Strategic Advisors’s United Therapeutics UTHR Stock Holding History

Schonfeld Strategic Advisors’s Portfolio UTHR Stock Details UTHR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$2.54M	Sell	4,290 -17,809	-81%	-$8.87M	0.02%	723
2025 Q4	$10.8M	Sell	22,099 -86,852	-80%	-$40.4M	0.05%	332
2025 Q3	$45.7M	Buy	108,951 +106,471	+4,293%	+$35.8M	0.32%	49
2025 Q2	$713K	Buy	2,480 +494	+25%	+$148K	0.01%	1430
2025 Q1	$612K	Sell	1,986 -2,414	-55%	-$827K	﹤0.01%	1500
2024 Q4	$1.55M	Sell	4,400 -1,733	-28%	-$637K	0.01%	936
2024 Q3	$2.2M	Sell	6,133 -14,389	-70%	-$4.86M	0.02%	840
2024 Q2	$6.54M	Sell	20,522 -65,101	-76%	-$17.2M	0.05%	480
2024 Q1	$19.7M	Buy	85,623 +1,028	+1%	+$232K	0.15%	172
2023 Q4	$18.6M	Buy	84,595 +35,523	+72%	+$8.19M	0.15%	173
2023 Q3	$11.1M	Buy	49,072 +9,672	+25%	+$2.23M	0.1%	323
2023 Q2	$8.7M	Buy	39,400 +7,631	+24%	+$1.69M	0.08%	375
2023 Q1	$7.11M	Sell	31,769 -48,649	-60%	-$12M	0.07%	359
2022 Q4	$22.4M	Buy	80,418 +54,790	+214%	+$13.8M	0.19%	140
2022 Q3	$5.37M	Sell	25,628 -2,195	-8%	-$491K	0.05%	510
2022 Q2	$6.56M	Buy	27,823 +25,923	+1,364%	+$5.27M	0.07%	389
2022 Q1	$341K	Sell	1,900 -11,300	-86%	-$2.15M	﹤0.01%	1610
2021 Q4	$2.85M	Sell	13,200 -12,430	-48%	-$2.44M	0.03%	606
2021 Q3	$4.73M	Buy	25,630 +21,930	+593%	+$4.32M	0.05%	456
2021 Q2	$664K	Sell	3,700 -9,800	-73%	-$1.87M	0.01%	1066
2021 Q1	$2.26M	Buy	+13,500	New	+$2.25M	0.03%	628
2020 Q3	–	Sell	-2,171	Closed	-$263K	–	1683
2020 Q2	$263K	Sell	2,171 -4,306	-66%	-$484K	0.01%	1036
2020 Q1	$614K	Buy	6,477 +470	+8%	+$44.7K	0.04%	516
2019 Q4	$529K	Sell	6,007 -67,096	-92%	-$5.9M	0.01%	724
2019 Q3	$5.83M	Buy	73,103 +60,503	+480%	+$4.87M	0.17%	154
2019 Q2	$984K	Buy	+12,600	New	+$1.18M	0.03%	444
2018 Q3	–	Sell	-17,900	Closed	-$2.02M	–	1035
2018 Q2	$2.02M	Buy	+17,900	New	+$1.97M	0.11%	265
2017 Q1	–	Sell	-1,600	Closed	-$229K	–	748
2016 Q4	$229K	Buy	+1,600	New	+$204K	0.03%	482